Refractory Kawasaki Disease—a Challenge for the Pediatrician

被引:8
|
作者
Deepu Abraham
Sridhar Kalyanasundaram
Kandamaran Krishnamurthy
机构
[1] Zulekha Hospital,
[2] Al Zahra Hospital,undefined
[3] Queen Elizabeth Hospital,undefined
关键词
Kawasaki disease; Atypical Kawasaki disease; Coronary dilation; IV immunoglobulin; Refractory Kawasaki disease; Coronary artery aneurysms; Intravenous immunoglobulin; Steroids; Infliximab; Plasma exchange;
D O I
10.1007/s42399-021-00775-w
中图分类号
学科分类号
摘要
Kawasaki disease (KD) is an acute, self-limiting febrile illness of childhood associated with vasculitis, mainly of the medium-sized arteries. The clinical significance and impact of this condition arise from its predilection for the coronary arteries. The criteria for classic Kawasaki disease are clearly defined, but many children present with atypical forms, and clinicians need to consider this possibility. Although most diagnosed cases respond to intravenous immunoglobulin (IVIG) and aspirin, some have proven resistant to the standard treatment. This article aims to provide a brief overview of Kawasaki disease, focusing on the resistant/refractory cases, and the treatment options available for such cases.
引用
收藏
页码:855 / 860
页数:5
相关论文
共 50 条
  • [31] Leucocoria in a boy with Kawasaki disease: a diagnostic challenge
    Che, Mahiran C. D.
    Alagaratnam, J.
    Liza-Sharmini, A. T.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (07) : E232 - E234
  • [32] Do cytokines correlate with refractory Kawasaki disease in children?
    Wang, Ying
    Qian, Su Yun
    Yuan, Yue
    Wang, Qin
    Gao, Lu
    Chen, Xi
    Yu, Xia
    Zhen, Zhen
    CLINICA CHIMICA ACTA, 2020, 506 : 222 - 227
  • [33] Severe cutaneous manifestations in a child with refractory Kawasaki disease
    Falcini, F.
    Ricci, L.
    Poggi, G. M.
    Simonini, G.
    Calabri, G. B.
    de Martino, M.
    RHEUMATOLOGY, 2006, 45 (11) : 1444 - 1445
  • [34] The effect of TNFα blockade in complicated, refractory Kawasaki disease
    Stenbog, E. V.
    Windelborg, B.
    Horlyck, A.
    Herlin, T.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 (04) : 318 - 321
  • [35] Sivelestat sodium hydrate treatment for refractory Kawasaki disease
    Ebata, Ryota
    Yasukawa, Kumi
    Nagai, Kazue
    Saito, Yuko
    Higashi, Kouji
    Homma, Jun
    Takada, Nobuyuki
    Takechi, Fumie
    Saito, Naoki
    Kobayashi, Hironobu
    Okunushi, Kentaro
    Hamada, Hiromichi
    Kohno, Yoichi
    Hanaoka, Hideki
    Shimojo, Naoki
    PEDIATRICS INTERNATIONAL, 2019, 61 (05) : 438 - 443
  • [36] Infliximab administration effective in the treatment of refractory Kawasaki Disease
    Accomando, Salvatore
    Liotta, Andrea
    Maggio, Maria Cristina
    Cardella, Francesca
    Corsello, Giovanni
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2010, 21 (07) : 1091 - 1092
  • [37] Refractory Kawasaki disease with coronary aneurysms treated with infliximab
    Salas Salguero, J.
    Gomez-Pastrana Duran, D.
    Salido Peracaula, C.
    Ruiz-Berdejo Iznardi, C.
    Ortiz Tardio, J.
    ANALES DE PEDIATRIA, 2010, 73 (05): : 268 - 271
  • [38] A Case of Refractory Kawasaki Disease Complicated by Peripheral Ischemia
    Na Yeon Kim
    Deok Young Choi
    Mi Jin Jung
    In-sang Jeon
    Pediatric Cardiology, 2008, 29 : 1110 - 1114
  • [39] Extremely refractory Kawasaki disease with disseminated intravascular coagulation
    Koh, Young Kwon
    Lee, Jae Hee
    Park, Yeong Bong
    CARDIOLOGY IN THE YOUNG, 2017, 27 (05) : 1004 - 1007
  • [40] A Case of Refractory Kawasaki Disease Complicated by Peripheral Ischemia
    Kim, Na Yeon
    Choi, Deok Young
    Jung, Mi Jin
    Jeon, In-sang
    PEDIATRIC CARDIOLOGY, 2008, 29 (06) : 1110 - 1114